UnitedHealth Group Incorporated (NYSE:UNH) Stake Lowered by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,627 shares of the healthcare conglomerate's stock after selling 1,470 shares during the quarter. Kornitzer Capital Management Inc. KS's holdings in UnitedHealth Group were worth $13,975,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC grew its stake in shares of UnitedHealth Group by 9.6% in the fourth quarter. Venturi Wealth Management LLC now owns 31,753 shares of the healthcare conglomerate's stock valued at $16,063,000 after buying an additional 2,770 shares in the last quarter. Fortis Group Advisors LLC grew its stake in shares of UnitedHealth Group by 1.0% in the fourth quarter. Fortis Group Advisors LLC now owns 6,042 shares of the healthcare conglomerate's stock valued at $3,056,000 after buying an additional 57 shares in the last quarter. Pittenger & Anderson Inc. grew its stake in shares of UnitedHealth Group by 0.3% in the fourth quarter. Pittenger & Anderson Inc. now owns 42,634 shares of the healthcare conglomerate's stock valued at $21,567,000 after buying an additional 136 shares in the last quarter. Human Investing LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $138,000. Finally, NTV Asset Management LLC boosted its holdings in UnitedHealth Group by 12.2% in the fourth quarter. NTV Asset Management LLC now owns 443 shares of the healthcare conglomerate's stock valued at $224,000 after purchasing an additional 48 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH stock traded down $36.84 during midday trading on Friday, reaching $465.58. The company had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a market capitalization of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.40 and a beta of 0.61. The stock has a 50 day moving average price of $519.27 and a 200 day moving average price of $560.54. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the company earned $5.83 earnings per share. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on UNH shares. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.